Uniformed Services University of the Health Sciences (USU) is a health science university of the U.S. federal government. The primary mission of the school is to prepare graduates for service to the U.S. at home and abroad as uniformed health professionals, scientists and leaders; by conducting cutting-edge, military-relevant research; by leading the Military Health System in key functional and intellectual areas; and by providing operational support to units around the world.
Edward Donnall "Don" Thomas was an American physician, professor emeritus at the University of Washington, and director emeritus of the clinical research division at the Fred Hutchinson Cancer Research Center. In 1990 he shared the Nobel Prize in Physiology or Medicine with Joseph E. Murray for the development of cell and organ transplantation. Thomas and his wife and research partner Dottie Thomas developed bone marrow transplantation as a treatment for leukemia.
Stephen Gould Emerson, M.D, Ph.D., was the 13th president of Haverford College from July 1, 2007, to August 10, 2011. In February 2012, he was appointed Director of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, and he will also hold the Clyde ’56 and Helen Wu Professorship in Immunology at the Columbia University Vagelos College of Physicians and Surgeons.
Eleanor Concepcion "Connie" Mariano, is a Filipina American physician and retired flag officer in the United States Navy. She is the first Filipino American and graduate of the Uniformed Services University of Medicine to reach the rank of Rear Admiral in the U.S. Navy as well as the second woman to become Physician to the President, a position that placed her as director of the White House Medical Unit.
Jonathan W. Simons is an American physician-scientist, medical oncologist, and leader in prostate cancer research. In August 2021, Simons was appointed the medical director and Chief Science Officer of the Marcus Foundation. Prior to joining the Marcus Foundation, he served a 14-year tenure as the President and chief executive officer of the Prostate Cancer Foundation. Simons’ laboratories, partly funded by the Prostate Cancer Foundation, at Johns Hopkins University and Emory University made original contributions to understanding the molecular biology of prostate cancer metastasis and principles of “broken immune tolerance” via T cell based immunotherapy for prostate cancer. The Simons lab invented GM-CSF genetically engineered vaccines for prostate cancer in rodents and humans for these studies, and subsequently Simons’ clinical team took the biotechnology into the world’s first human gene therapy clinical trials for advanced prostate cancer at Johns Hopkins.
Gregory J. Martin is an American medical doctor and captain in the United States Navy. Martin is a recognized expert in the fields of infectious diseases and bioterrorism.
George Quentin Daley is the Dean of the Faculty of Medicine, Caroline Shields Walker Professor of Medicine, and Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. He was formerly the Robert A. Stranahan Professor of Pediatrics at Harvard Medical School, Director of the Stem Cell Transplantation Program at Boston Children's Hospital, and an investigator of the Howard Hughes Medical Institute, Associate Director of Children's Stem Cell Program, a member of the Executive Committee of the Harvard Stem Cell Institute. He is a past president of the International Society for Stem Cell Research (2007–2008).
Edith A. Pérez is a Puerto Rican hematologist-oncologist. She is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic Alix School of Medicine.
Lorenzo Cohen is a professor in the Department of General Oncology and Behavioral Science and the director of the Integrative Medicine Program at the University of Texas MD Anderson Cancer Center. He is also a distinguished clinical professor at the Fudan University Shanghai Cancer Center in Shanghai, China. Cohen is a founding member and past president of the Society for Integrative Oncology.
Luisa Massimo was an Italian pediatrician. From 1972 to 1997 she was the director of the 4th Division of Pediatrics of the Children's Hospital Istituto Giannina Gaslini of Genoa. From 1998 she is director emeritus. She is internationally considered one of the founders of Pediatric oncology
Michael A. Caligiuri is an American physician scientist focused on oncology and immunology. He is currently the president of the City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair. He was elected president of the American Association for Cancer Research, the world's largest cancer research organization, for 2017–2018. He was previously the CEO of the James Cancer Hospital (2008-2017), Director of the Comprehensive Cancer Center (2003-2017), and Director of the Division of Hematology-Oncology (2000-2008) at the Ohio State University. He was elected to the United States National Academy of Medicine in 2018.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.
Hope S. Rugo is professor of medicine and the director of the breast oncology clinical trials program at the University of California at San Francisco, and an investigator of SPORE in the Bay Area.
Ravi Salgia is an Indian-American oncologist who is the Arthur & Rosalie Kaplan Chair and Professor in Medical Oncology at the Comprehensive Cancer Center of City of Hope. Salgia serves on multiple National Cancer Institute panels. He has received research grants from the NIH for his work and has been granted several invention discoveries and patents concerning his research and became the Fellow of the Royal Society of Medicine. He has written 800 articles, reviews, and editorials with peer review, two books, and 34 book chapters.
Brian G.M. Durie is a Scottish hematologist known for his research and efforts regarding multiple myeloma and blood disorders, especially his development of the multiple myeloma staging system. He is the chairman of the board and Scientific Director for the Myeloma Foundation and a specialist in multiple myeloma and related disorders at the Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute ..
Kendall A. Smith is an American scientist most well-known for his work on interleukins, the regulatory molecules of the immune system, which has led to many of the new present-day therapies for immunological disorders, transplant rejection, infectious diseases and cancer. Smith is a Professor Emeritus of Medicine at Weill Cornell Medicine.
Leonidas C. Platanias is a Greek-American oncologist. He is the director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Jesse, Sara, Andrew, Abigail, Benjamin and Elizabeth Lurie Professor of Oncology. He is internationally known for his research focused on cytokine signaling pathways in cancer cells, and for his contributions in developing therapies that target those pathways.
Bob Löwenberg is a clinical hematologist/investigator. He is Professor of Hematology at Erasmus University Rotterdam.
Michael L. Cowan is a retired American navy admiral who is a former Surgeon General of the United States Navy.
Jonathan D. Licht is an American physician who has served as director of the University of Florida Health Cancer Center since 2015, holding The Marshall E. Rinker Sr. Rinker Chair. Licht led the UF Health Cancer Center to achieve designation from the National Cancer Institute in June 2023.
